CD86 and neoplasm: For example, we observed significantly a lower percentage of I-A/I-E expressing cells, a higher frequency of CD80 expressing cells without any change in the proportion of CD86 expressing cells among Dectin-1+ myeloid cells in the spleen of B16 tumour model (Fig. 1F, G).